Faeth Therapeutics, Inc. (FTH)

Faeth Therapeutics, Inc. (FTH) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $733M; returns 1 day -15.0%, 1 week -9.1%.

Faeth Therapeutics, Inc. (formerly Sensei Biotherapeutics) is a clinical-stage biotechnology company that transitioned into its current form in June 2026 following the acquisition of the legacy Faeth Therapeutics entity and a corporate rebranding.

Groups FTH belongs to

• Clinical Stage
• Biotechnology
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Clinical Stage Biotech
• Precision Medicine
• Metabolic Disorders
• Monoclonal Antibodies
• Healthcare
• Life Sciences

FTH financial model: income statement, cash flow and balance sheet